Ruth A Keri

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Topics

Transcription Factor

Breast Cancer Cells

Endoplasmic Reticulum

Top Venues

Cancer research

The Journal of biological chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Katrina M Piemonte, Natasha N Ingles, Kristen L Weber Bonk, Mitchell J Valentine, Parth R Majmudar, Salendra Singh, Ruth A Keri
Targeting YES1 Disrupts Mitotic Fidelity and Potentiates the Response to Taxanes in Triple-Negative Breast Cancer. Cancer research (2024)
Anthony Caputo, Kavya Vipparthi, Peter Bazeley, Erinn Downs-Kelly, Patrick J McIntire, Lauren Ashley Duckworth, Ying Ni, Bo Hu, Ruth A Keri, Mihriban Karaayvaz-Yildirim
Spatial transcriptomics suggests that alterations occur in the preneoplastic breast microenvironment of BRCA1/2 mutation carriers. Molecular cancer research : MCR (2023)
Lindsey J Anstine, Parth R Majmudar, Amy Aponte, Salendra Singh, Ran Zhao, Kristen L Weber Bonk, Fadi W Abdul-Karim, Mitchell J Valentine, Darcie D Seachrist, Katelyn E Grenell-Nickelson, Leslie Cuellar-Vite, Gina M Sizemore, Steven T Sizemore, Bryan M Webb, Cheryl L Thompson, Ruth A Keri
TLE3 Sustains Luminal Breast Cancer Lineage Fidelity to Suppress Metastasis. Cancer research (2023)
Jessica R Bobbitt, Darcie D Seachrist, Ruth A Keri
Chromatin organization and transcriptional programming of breast cancer cell identity. Endocrinology (2023)
Abhishek A Chakraborty, Ruth A Keri
The GR-PDK4 Axis of Evil: Hijacking a Stress SOS to Drive Metastasis. Endocrinology (2023)
Leslie Cuellar-Vite, Kristen L Weber-Bonk, Fadi W Abdul-Karim, Christine N Booth, Ruth A Keri
Focal Adhesion Kinase Provides a Collateral Vulnerability That Can Be Leveraged to Improve mTORC1 Inhibitor Efficacy. Cancers 14 (14) (2022)
Katrina M Piemonte, Lindsey J Anstine, Ruth A Keri
Centrosome Aberrations as Drivers of Chromosomal Instability in Breast Cancer. Endocrinology 162 (12) (2022)
Darcie D Seachrist, Lindsey J Anstine, Ruth A Keri
FOXA1: A Pioneer of Nuclear Receptor Action in Breast Cancer. Cancers 13 (20) (2021)
Melyssa S Roberts, Jennifer M Sahni, Morgan S Schrock, Katrina M Piemonte, Kristen L Weber-Bonk, Darcie D Seachrist, Stefanie Avril, Lindsey J Anstine, Salendra Singh, Steven T Sizemore, Vinay Varadan, Matthew K Summers, Ruth A Keri
LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance. Cancer research 80 (8) (2020)
Melyssa S Roberts, Lindsey J Anstine, Viviane S Finke, Benjamin L Bryson, Bryan M Webb, Kristen L Weber-Bonk, Darcie D Seachrist, Parth R Majmudar, Ruth A Keri
KLF4 defines the efficacy of the epidermal growth factor receptor inhibitor, erlotinib, in triple-negative breast cancer cells by repressing the EGFR gene. Breast cancer research : BCR 22 (1) (2020)
Darcie D Seachrist, Molly M Hannigan, Natasha N Ingles, Bryan M Webb, Kristen L Weber-Bonk, Peng Yu, Gurkan Bebek, Salendra Singh, Steven T Sizemore, Vinay Varadan, Donny D Licatalosi, Ruth A Keri
The transcriptional repressor BCL11A promotes breast cancer metastasis. The Journal of biological chemistry 295 (33) (2020)
Sylvia S Gayle, Jennifer M Sahni, Bryan M Webb, Kristen L Weber-Bonk, Melyssa S Shively, Raffaella Spina, Eli E Bar, Mathew K Summers, Ruth A Keri
Targeting BCL-xL improves the efficacy of bromodomain and extra-terminal protein inhibitors in triple-negative breast cancer by eliciting the death of senescent cells. The Journal of biological chemistry 294 (3) (2018)